Achieve Life Sciences Inc.

4.70+0.3200+7.31%Vol 30.11K1Y Perf -39.84%
Mar 22nd, 2023 15:37 DELAYED
BID4.66 ASK4.70
Open4.44 Previous Close4.38
Pre-Market4.88 After-Market-
 0.50 11.42%  - -
Target Price
26.80 
Analyst Rating
Strong Buy 1.00
Potential %
470.21 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★★ —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
44.08 
Earnings Rating
Neutral
Market Cap84.27M 
Earnings Date
11th May 2023
Alpha-0.06 Standard Deviation0.25
Beta1.23 

Today's Price Range

4.444.70

52W Range

2.008.13

5 Year PE Ratio Range

-1.10-0.4000

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Sell
Performance
1 Week
-3.95%
1 Month
-16.09%
3 Months
77.33%
6 Months
8.15%
1 Year
-39.84%
3 Years
-26.76%
5 Years
-98.35%
10 Years
-99.98%

TickerPriceChg.Chg.%
ACHV4.700.32007.31
AAPL159.20-0.0800-0.05
GOOG105.33-0.5100-0.48
MSFT274.620.84000.31
XOM105.30-1.7400-1.63
WFC37.50-0.9791-2.54
JNJ152.00-1.8893-1.23
FB196.640.99000.51
GE90.39-1.7900-1.94
JPM127.86-2.6900-2.06
 
Earnings HistoryEstimateReportedSurprise %
Q04 2022-0.90-0.837.78
Q03 2022-1.10-1.35-22.73
Q02 2022-0.79-1.08-36.71
Q01 2022-0.82-0.802.44
Q04 2021-0.73-0.76-4.11
Q03 2021-1.09-0.7134.86
Q02 2021-1.23-1.53-24.39
Q01 2021-0.78-1.30-66.67
Earnings Per EndEstimateRevision %Trend
12/2022 QR-0.982.00Positive
12/2022 FY-4.14-6.70Negative
3/2023 QR-0.891.11Positive
12/2023 FY-2.4214.49Positive
Next Report Date11th May 2023
Estimated EPS Next Report-0.65
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume30.11K
Shares Outstanding17.93K
Shares Float9.66M
Trades Count458
Dollar Volume139.81K
Avg. Volume100.04K
Avg. Weekly Volume108.35K
Avg. Monthly Volume88.40K
Avg. Quarterly Volume103.36K

Achieve Life Sciences Inc. (NASDAQ: ACHV) stock closed at 4.38 per share at the end of the most recent trading day (a 0% change compared to the prior day closing price) with a volume of 119.86K shares and market capitalization of 84.27M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 14 people. Achieve Life Sciences Inc. CEO is John Bencich.

The one-year performance of Achieve Life Sciences Inc. stock is -39.84%, while year-to-date (YTD) performance is 78.78%. ACHV stock has a five-year performance of -98.35%. Its 52-week range is between 2 and 8.125, which gives ACHV stock a 52-week price range ratio of 44.08%

Achieve Life Sciences Inc. currently has a PE ratio of -0.70, a price-to-book (PB) ratio of 44.74, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -137.30%, a ROC of -148.59% and a ROE of -251.44%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Achieve Life Sciences Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.65 for the next earnings report. Achieve Life Sciences Inc.’s next earnings report date is 11th May 2023.

The consensus rating of Wall Street analysts for Achieve Life Sciences Inc. is Strong Buy (1), with a target price of $26.8, which is +470.21% compared to the current price. The earnings rating for Achieve Life Sciences Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Achieve Life Sciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Achieve Life Sciences Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 21.96, ATR14 : 0.35, CCI20 : -77.61, Chaikin Money Flow : -0.15, MACD : -0.13, Money Flow Index : 34.12, ROC : -14.45, RSI : 41.85, STOCH (14,3) : 16.39, STOCH RSI : 0.53, UO : 37.62, Williams %R : -83.61), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Achieve Life Sciences Inc. in the last 12-months were: Anthony Clarke (Option Excercise at a value of $0), Cindy Jacobs (Option Excercise at a value of $0), Jerry Wan (Option Excercise at a value of $0), John Bencich (Buy at a value of $0), John Bencich (Option Excercise at a value of $0), Richard Alistair Balfour Stewart (Option Excercise at a value of $0)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
3 (100.00 %)
4 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the global smoking health epidemic through the development and commercialization of cytisinicline.

CEO: John Bencich

Telephone: +1 425 686-1500

Address: 520 Pike Street, Seattle 98101, WA, US

Number of employees: 14

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

33%67%

Bearish Bullish

56%44%

Bearish Bullish

58%42%

Bearish Bullish

58%42%

TipRanks News for ACHV

Sat, 18 Mar 2023 13:25 GMT Achieve Life Sciences (ACHV) Gets a Buy from Maxim Group

- TipRanks. All rights reserved.

Fri, 17 Mar 2023 12:30 GMT Analysts Are Bullish on These Healthcare Stocks: Achieve Life Sciences (ACHV), Liquidia Technologies (LQDA)

- TipRanks. All rights reserved.

Thu, 09 Mar 2023 19:45 GMT Achieve Life Sciences (ACHV) Receives a Buy from Maxim Group

- TipRanks. All rights reserved.

News

Stocktwits